Trial intelligence / Profile preview

Parecoxib for postoperative pain and local inflammation after total knee arthroplasty

ChiCTR-TRC-10000968Phase 4Completed

Sponsor
Shanghai Changzheng Hospital
Start
Dec 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of parecoxib in postoperative pain and osteoarthritis (OA) (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoint: Morphine consumption. Started Dec 2009; status: completed.

02

Drugs

parecoxib
03

Conditions

postoperative painosteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR-TRC-10000968.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10000968.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call